Skip to main content

Want a detailed portfolio tracker?

Liminatus Pharma (LIMN) P/E (2025 - 2026)

Liminatus Pharma (LIMN) P/E from May 1, 2025 to Jul 21, 2026. The TTM Liminatus Pharma (LIMN) P/E is -0.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Liminatus Pharma (LIMN)

YearP/EChange
2026-0.29-79.94%
2025-1.42N/A

Comparison Liminatus Pharma (LIMN) P/E with competitors

Liminatus Pharma (LIMN) P/E is -0.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.60%
NBYStablecoin Development Corp0.00-101.51%
ENLVEnlivex Ltd0.07-126.21%
FGENFibroGen Inc0.24-184.10%
CHRSCoherus Biosciences Inc0.85-397.30%
FBIOFortress Biotech Inc0.95-432.51%
ORMPOramed Pharmaceuticals Inc1.50-626.63%
AGENAgenus Inc3.01-1154.48%
INVAInnoviva Inc3.15-1205.07%
VXRTVaxart Inc3.55-1343.72%
CRMDCorMedix Inc3.63-1371.30%
CVACCureVac N.V.4.45-1657.63%
GLPGGalapagos NV4.86-1802.41%
SRPTSarepta Therapeutics Inc4.88-1810.54%
ABEOAbeona Therapeutics Inc5.39-1987.62%
ABUSArbutus Biopharma Corp5.60-2060.54%
ZVRAZevra Therapeutics Inc5.89-2162.71%
SPROSpero Therapeutics Inc6.23-2282.26%
CGENCompugen Ltd6.31-2312.22%
RIGLRigel Pharmaceuticals6.87-2507.77%
SLXNSilexion Therapeutics Corp7.30-2656.33%
OMEROmeros Corporation9.26-3343.99%
AUPHAurinia Pharmaceuticals Inc9.58-3458.29%
PLXProtalix BioTherapeutics Inc10.89-3915.89%
ACADAcadia Pharmaceuticals Inc11.73-4209.33%
TBPHTheravance Biopharma Inc12.26-4396.30%
ADMAAdma Biologics Inc12.42-4450.96%
HRMYHarmony Biosciences Holdings Inc13.82-4942.19%
SABSSAB Biotherapeutics Inc14.14-5052.92%
NAGENiagen Bioscience Inc14.82-5291.84%
INCYIncyte Corp15.82-5643.77%
REGNRegeneron Pharmaceuticals Inc15.86-5655.72%
PBYIPuma Biotechnology Inc17.32-6166.93%
CPRXCatalyst Pharmaceuticals Inc17.44-6210.23%
EXELExelixis Inc17.54-6244.82%
TGTXTG Therapeutics Inc18.97-6745.16%
MDXGMimedx Group Inc20.55-7301.01%
XOMAXOMA Royalty Corp22.87-8114.85%
ARGXArgen X SE24.30-8613.55%
CTMXCytomX Therapeutics Inc24.82-8796.83%
XOMAOXOMA Royalty Corp25.34-8980.33%
HALOHalozyme Therapeutics Inc25.62-9078.05%
XOMAPXOMA Royalty Corp25.67-9094.31%
VRTXVertex Pharmaceuticals Inc27.99-9908.81%
RPRXRoyalty Pharma plc - Class A28.69-10151.56%
SLNOSoleno Therapeutics Inc29.02-10266.41%
ASNDAscendis Pharma A/S30.09-10641.39%
APLSApellis Pharmaceuticals Inc39.02-13772.28%
BMRNBiomarin Pharmaceutical Inc42.21-14890.21%
KRYSKrystal Biotech Inc45.34-15987.47%
ONCBeiGene Ltd69.54-24465.63%
PHARPharming Group N.V.75.03-26387.52%
TECHBio-Techne Corp101.96-35824.26%
VCELVericel Corp109.92-38614.33%
ALNYAlnylam Pharmaceuticals Inc117.96-41432.71%
GMABGenmab140.29-49255.20%
TLXTelix Pharmaceuticals Ltd162.15-56915.24%
CORTCorcept Therapeutics Inc212.86-74681.19%